AXIM BIOTECHNOLOGIES, INC. Gain (Loss) Related to Litigation Settlement
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Gain (Loss) Related to Litigation Settlement of $955.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2024-04-16
- AXIM BIOTECHNOLOGIES, INC. gain (loss) related to litigation settlement for the quarter ending 2023-12-31 was $728.83K.
- AXIM BIOTECHNOLOGIES, INC. gain (loss) related to litigation settlement for the quarter ending 2023-09-30 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. gain (loss) related to litigation settlement for the quarter ending 2023-06-30 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. gain (loss) related to litigation settlement for the quarter ending 2023-03-31 was $226.17K.
- AXIM BIOTECHNOLOGIES, INC. gain (loss) related to litigation settlement for fiscal 2023 was $955.00K.
- AXIM BIOTECHNOLOGIES, INC. gain (loss) related to litigation settlement for fiscal 2022 was $0.00.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month | Gain (Loss) Related to Litigation Settlement 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $728.83K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $728.83K derived: sum of 2 quarters · filed 2024-04-16 | $728.83K derived: sum of 3 quarters · filed 2024-04-16 | $955.00K 10-K · filed 2024-04-16 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $0.00 derived: sum of 2 quarters · filed 2023-11-20 | $226.17K 10-Q · filed 2023-11-20 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $226.17K 10-Q · filed 2023-08-21 | |||
| 2023-03-31 | $226.17K 10-Q · filed 2023-05-22 | ||||
| 2022-12-31 | $0.00 10-K · filed 2024-04-16 | $226.17K 10-K · filed 2023-04-17 | |||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | ||||
| 2019-06-30 | $0.00 10-Q/A · filed 2020-11-27 |